OTC Watch

All stocks / PBSV

Pharma-Bio Serv, Inc. PBSV

Pharma-Bio Serv (PBSV): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCQBPuerto Rico, USA
Live quote on OTC Markets

Market listing

Full name
PHARMA-BIO SERVICES INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

News headlines

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026
2026-09-14 17:20 · News Release
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
2026-06-15 17:01 · News Release
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
2026-03-17 17:06 · News Release
Pharma-Bio Serv Announces Full Year Results and Special Dividend
2026-01-29 17:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-10-31
The report says
Revenue
$9,001,096
Net loss
($100,463)
What it means

It spends more than it earns

Under strain

Customers paid it $9 million in the year. It lost $100,463. For every $1 that came in, about $1.01 went out.

The report says
Cash and cash equivalents
$3,379,212
Net cash used in operating activities
($214,886)
What it means

It has cash for a while

Steady

It had $3.4 million in the bank and used about $17,907 a month. At that pace the money lasts about 189 months unless it borrows or sells more shares.

The report says
Total assets
$13,653,046
Total liabilities
$1,738,799
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $13.7 million. Its debts and unpaid bills add up to $1.7 million. That is about $0.13 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-09-10

Estimated float about 22,901,692 shares as of 2026-09-10: 22,901,692 outstanding minus 0 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2026-01-23
22.9M
2026-01-31
22.9M
2026-02-23
22.9M
2026-03-13
22.9M
2026-04-30
22.9M
2026-06-10
22.9M
2026-07-31
22.9M
2026-09-10
22.9M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-09-14 10-QFORM 10-Q
2026-09-14 8-KFORM 8-K
2026-07-22 4PRIMARY DOCUMENT
2026-06-15 10-QFORM 10-Q
2026-06-15 8-KFORM 8-K
2026-05-15 8-KFORM 8-K
2026-04-16 DEF 14ADEF 14A
2026-04-16 ARSARS
2026-03-17 10-QFORM 10-Q
2026-03-17 8-KFORM 8-K
2026-02-27 10-K/AFORM 10-K/A
2026-01-29 10-KFORM 10-K

Common questions about PBSV

Does PBSV file reports with the SEC?

Yes. Pharma-Bio Serv files with the SEC under company number 0001304161. The most recent filing we hold is a 10-Q dated 2026-09-14.

Source record

How many PBSV shares are outstanding?

22,901,692 shares as of 2026-09-10, as reported to the SEC.

Source record

Has PBSV filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Who runs Pharma-Bio Serv?

Officers named in its insider filings: Kirk Wheeler Michel (Chairman).

Source record

Is Pharma-Bio Serv making money?

Customers paid it $9 million in the year. It lost $100,463. For every $1 that came in, about $1.01 went out. (Annual figures to 2025-10-31. Facts from the company's own report, not a recommendation.)

Source record